Antecedent viral immunization and efficacy of immune checkpoint blockade: an extensive serum antibody profile to predict outcomes in non-small cell lung cancer
Introduction Immune checkpoint blockers (ICBs) revolutionized the treatment of patients with advanced non-small cell lung cancer (NSCLC) but only a fraction of them obtain a response, and clinical benefit from these treatments is often difficult to predict. The aim of our study is to unveil the pote...
| 发表在: | Journal for ImmunoTherapy of Cancer |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| 格式: | 文件 |
| 语言: | 英语 |
| 出版: |
BMJ Publishing Group
2024-11-01
|
| 在线阅读: | https://jitc.bmj.com/content/12/11/e009931.full |
